Susquehanna International Group
CSBR icon

Susquehanna International Group’s Champions Oncology CSBR Stock Holding History

Susquehanna International Group’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,600
Closed -$144K – 12604
2025
Q2 		$144K Sell
19,600
-9,200
-32% -$64.9K ﹤0.01% 11529
2025
Q1 		$250K Buy
28,800
+13,700
+91% +$139K ﹤0.01% 10474
2024
Q4 		$129K Buy
+15,100
New +$76K ﹤0.01% 11131
2024
Q1 		– Sell
-12,000
Closed -$64.9K – 12329
2023
Q4 		$64.9K Sell
12,000
-1,400
-10% -$7.81K ﹤0.01% 11595
2023
Q3 		$83.3K Buy
+13,400
New +$84.7K ﹤0.01% 11047
2022
Q4 		– Sell
-64,800
Closed -$486K – 12587
2022
Q3 		$486K Buy
64,800
+7,900
+14% +$66.1K ﹤0.01% 8570
2022
Q2 		$460K Buy
56,900
+20,400
+56% +$156K ﹤0.01% 8488
2022
Q1 		$297K Buy
+36,500
New +$293K ﹤0.01% 10299

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's CSBR Position: Q4 2025 in Review

Susquehanna International Group sold out of Champions Oncology (CSBR) in Q4 2025, closing a stake of 19,811 shares — an estimated $128K sold.

Susquehanna International Group first reported a position in CSBR in Q3 2018 and held it in 7 quarters. The position peaked at $1.1M in Q1 2025. 27 funds tracked by Wall St. Rank hold CSBR as of Q4 2025.

  • Susquehanna International Group reported no remaining Champions Oncology position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 19,811 Champions Oncology shares in Q4 2025, an estimated $128K.
  • Susquehanna International Group first reported a position in Champions Oncology in Q3 2018 and held it in 7 quarters.
  • Susquehanna International Group's Champions Oncology position peaked at $1.1M in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.